PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2013.45.4.2852013454285-294Nomogram to Predict Treatment Outcome of Fluoropyrimidine/Platinum-Based Chemotherapy in Metastatic Esophageal Squamous Cell CarcinomaHyun Ae Jung, Antoine Adenis, Jeeyun Lee, Se Hoon Park, Chi Hoon Maeng, Silvia Park, Hee Kyung Ahn, Young Mog Shim, Nicolas Penel, Young-Hyuck Imhttp://www.e-crt.org/upload/pdf/crt-45-285.pdf, http://www.e-crt.org/upload/pdf/crt-45-285.pdf
The Oncologist10.1002/onco.136462021264318-324Benefit–Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine- and Platinum-Based ChemotherapyLorraine Pelosof, May Tun Saung, Martha Donoghue, Sandra Casak, Sirisha Mushti, Joyce Cheng, Xiling Jiang, Jiang Liu, Hong Zhao, Maryam Khazraee, Kirsten B. Goldberg, Marc Theoret, Steven Lemery, Richard Pazdur, Lola Fashoyin-Ajehttps://onlinelibrary.wiley.com/doi/pdf/10.1002/onco.13646, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/onco.13646, https://academic.oup.com/oncolo/article-pdf/26/4/318/41923699/oncolo_26_4_318.pdf, https://academic.oup.com/oncolo/article-pdf/26/4/318/41923699/oncolo_26_4_318.pdf
Value in Health10.1016/j.jval.2021.11.12892022251S264POSC388 Treatment Patterns and Healthcare-Resource Utilization Among Patients with Advanced Esophageal Squamous Cell Carcinoma Who Received Platinum and Fluoropyrimidine Treatment at First LineD Jaffe, A Boudoures, J Gricarhttps://api.elsevier.com/content/article/PII:S1098301521030849?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301521030849?httpAccept=text/plain
International Immunopharmacology10.1016/j.intimp.2020.107178202190107178A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinomaShuai Liang, Chengming Li, Zhenhua Gao, Jianing Li, Heng Zhao, Jinming Yu, Xue Menghttps://api.elsevier.com/content/article/PII:S1567576920336456?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1567576920336456?httpAccept=text/plain
Medicine10.1097/md.0000000000033282202310211e33282A nomogram based on hematological markers to predict radiosensitivity in patients with esophageal squamous cell carcinomaLijun Sun, Peng Wei, Shuang Ge, Jie Zheng, Shucheng Ye, Yanhui Zhanghttps://journals.lww.com/10.1097/MD.0000000000033282
Esophageal Squamous Cell Carcinoma10.1007/978-981-15-4190-2_152020253-282Chemotherapy and ChemoradiotherapyKen Katohttp://link.springer.com/content/pdf/10.1007/978-981-15-4190-2_15
Esophageal Squamous Cell Carcinoma10.1007/978-4-431-54977-2_122014197-225Chemotherapy and ChemoradiotherapyKen Katohttps://link.springer.com/content/pdf/10.1007/978-4-431-54977-2_12
Annals of Oncology10.1016/j.annonc.2020.10.143202031S1290-S1291122P Nomogram to predict short-term effect of radiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinomaS. Liang, H. Zhao, C. Li, X. Menghttps://api.elsevier.com/content/article/PII:S0923753420426341?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420426341?httpAccept=text/plain
Esophageal Squamous Cell Carcinoma10.1007/978-4-431-54977-2_2201413-32Pathology of Esophageal Squamous Cell CarcinomaYukihiro Nakanishihttps://link.springer.com/content/pdf/10.1007/978-4-431-54977-2_2
Diseases of the Esophagus10.1093/dote/doac051.231202235Supplement_2231. A NOMOGRAM BASED ON BODY MASS INDEX CHANGES TO PREDICT PROGNOSIS AFTER CURATIVE RESECTION OF ESOPHAGEAL SQUAMOUS CELL CARCINOMALong-Qi Chen, Yi-Min Guhttps://academic.oup.com/dote/article-pdf/35/Supplement_2/doac051.231/45981576/doac051.231.pdf, https://academic.oup.com/dote/article-pdf/35/Supplement_2/doac051.231/45981576/doac051.231.pdf